PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Four-hundred twelve patients, who were confirmed to have no previous or current CVDs NAFLD diagnosis, underwent analysis to determine the cumulative incidence rates of CVDs according to PNPLA3 genotype.